Cencora

Current directors and officers who also hold a role at another S&P 500 company.

• Lori RyerkerkETN · DirectorNSC · Director
• Dennis M. NallyMS · Director
• Eva C. BorattoUPS · Director
• Lauren M. TylerCNC · Director

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Sep 25, 2026

   Director Appointment On September 24, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Robert E. Sanchez to serve on the Board (the “Appointment”), effective October 1, 2026 (the “Effective Date”). In connection with the Appointment, the Board increased from ten to eleven members in accordance with the Company’s Amended and Restated Bylaws. Mr. Sanchez will receive the same benefits and compensation as the other non-employee directors on the Board pursuant to the Company’s Compensation Policy for Non-Employee Directors, as described on pages 40 to 41 of the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on January 22, 2026.

   Read the 8-K filing
2. Aug 14, 2026

   On August 13, 2026, following the conclusion of the quarterly meeting of the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”), Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately. Dr. Kim’s decision was made in connection with his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. and his need to devote additional time to his professional responsibilities at that company. Dr. Kim has advised the Company that his resignation is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company thanks Dr. Kim for his dedicated service.

   Read the 8-K filing
3. Jun 15, 2026

   On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026. Ms. Battaglia will serve in an advisory capacity through the end of 2026. Ms. Battaglia’s decision to retire from her position was not the result of a disagreement on any matter related to the Company’s operations, policies or practices. Ms. Battaglia will be succeeded by Samantha L. Hammock, who will join the Company as Executive Vice President and Chief Human Resources Officer effective July 13, 2026. Ms. Hammock most recently served as Executive Vice President and Chief Human Resources Officer of Verizon Communications Inc.

   Read the 8-K filing
4. May 29, 2026

   On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”). Ms. Boratto succeeds James F. Cleary, who will be retiring from his role as Executive Vice President and Chief Financial Officer as previously disclosed. Mr. Cleary will serve in an advisory capacity through the end of 2026. Ms. Boratto, age 59, most recently served as Chief Financial Officer of Bath & Body Works, Inc. since August 2023. Prior to that, she served as Chief Financial Officer of Opentrons Labwork Inc., a privately held life sciences company, from February 2022 to July 2023.

   Read the 8-K filing
5. Mar 17, 2026

   On March 17, 2026, Cencora, Inc. (the “Company”) announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer of the Company effective June 30, 2026. Mr. Cleary’s decision to retire from his position was not the result of a disagreement on any matter related to the Company’s operations, policies or practices.

   Read the 8-K filing
6. Jan 22, 2026

   Director Appointment On January 20, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Ellen G. Cooper to serve on the Board (the “Appointment”), effective immediately. In connection with the Appointment, the Board increased from ten to eleven members in accordance with the Company’s Amended and Restated Bylaws. Ms. Cooper will receive the same benefits and compensation as the other non-employee directors on the Board pursuant to the Company’s Compensation Policy for Non-Employee Directors, as described on pages 40 to 41 of the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on January 23, 2025.

   Read the 8-K filing
7. Aug 27, 2025

   On August 27, 2025, Cencora, Inc. (the “Company”) announced that its Board of Directors (the “Board”) has appointed D. Mark Durcan as Chairman of the Board, effective October 1, 2025. Mr. Durcan has served as a director of the Company since September 2015 and as the Board’s Lead Independent Director since March 2023. Mr. Durcan will succeed Steven H. Collis who confirmed to the Board that, as previously reported, he will retire as Executive Chairman of the Board and as a director, effective at the end of the Company’s fiscal year ending September 30, 2025. As a result of Mr. Collis stepping down from the Board, the size of the Board will be reduced from 11 to 10 directors, effective upon his retirement. Mr. Collis’ decision to retire from the Board was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

   Read the 8-K filing
8. May 28, 2025

   Director Appointment On May 21, 2025, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Lori J. Ryerkerk to serve on the Board (the “Appointment”), with such Appointment to be effective as of June 1, 2025 (the “Appointment Date”). Ms. Ryerkerk will receive the same benefits and compensation as the other non-employee directors on the Board pursuant to the Company’s Compensation Policy for Non-Employee Directors, as described on pages 40 to 41 of the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on January 23, 2025. All such compensation, including the non-employee director annual equity award, will be pro-rated for the period beginning on the Appointment Date and ending on the date of the Company’s 2026 Annual Meeting of Stockholders. There are no arrangements or understandings between Ms.

   Read the 8-K filing
9. Jan 22, 2025

   On January 22, 2025, two members of the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”), Richard W. Gochnauer and Kathleen W. Hyle, each informed the Company of their intent to retire as directors at the upcoming Annual Meeting of Stockholders to be held on March 6, 2025 (the “Annual Meeting”). Mr. Gochnauer and Ms. Hyle each indicated an intent to continue to serve as a director of the Company until the Annual Meeting and advised the Company that there were no disagreements between the Company and them relative to their intent to retire from the Board. Effective as of the date of the Annual Meeting, the size of the Board will be reduced from 13 members to 11. Mr. Gochnauer has served as a director of the Company since 2008 and currently serves as a member of the Board’s Audit Committee and Compliance and Risk Committee. Ms.

   Read the 8-K filing
10. Aug 16, 2024

    Named Executive Officer Employment Agreements On August 13, 2024, the Compensation and Succession Planning Committee of the Board (the “Committee”) approved a new form of Employment Agreement (the “Employment Agreement”) to be entered into with certain executive officers of the Company. As a result of such approval, the following named executive officers (together, the “NEOs” and each, an “NEO”) will enter into the Employment Agreement with the Company: James F. Cleary, the Company’s Executive Vice President and Chief Financial Officer, and Elizabeth S. Campbell, the Company’s Executive Vice President and Chief Legal Officer. Upon the execution of their respective Employment Agreements, any and all prior employment agreements with such NEOs will be superseded and replaced by the terms and conditions of the Employment Agreement.

    Read the 8-K filing
11. Aug 15, 2024

    Director Appointment On August 13, 2024, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Frank Clyburn to serve on the Board (the “Appointment”), with such Appointment to be effective as of October 1, 2024 (the “Effective Date”). In connection with the Appointment and the previously-disclosed appointment of Robert P. Mauch to the Board (also effective as of the Effective Date), the Board will increase from eleven to thirteen members in accordance with the Company’s Amended and Restated Bylaws as of the Effective Date. Mr.

    Read the 8-K filing
12. May 3, 2024

    On April 30, 2024, Gina K. Clark, Executive Vice President and Chief Communications & Administrative Officer of Cencora, Inc. (the “Company”), informed the Company that she intends to retire from her position, effective September 30, 2024. Ms. Clark’s decision to retire from her position was not the result of any disagreements with the Company’s management or Board of Directors as to any matter relating to the Company’s operations, finances, policies, or practices.

    Read the 8-K filing
13. Mar 15, 2024

    of the Current Report on Form 8-K filed on March 12, 2024 (the “Original Form 8-K”) by Cencora, Inc. (the “Company”), which disclosed (i) that Steven H. Collis will retire from the role of Chief Executive Officer (“CEO”) effective October 1, 2024 (the “Effective Date”) and become Executive Chairman of the Board of Directors of the Company (the “Board”) as of such date and (ii) the appointment of Robert P. Mauch as the Company’s President and CEO, as of the Effective Date, at which time Mr. Mauch will also join the Board. The sole purpose of this Amendment is to provide Messrs. Collis and Mauch’s compensation arrangements in connection with their new positions as of the Effective Date.

    Read the 8-K filing
14. Mar 12, 2024

    Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On March 11, 2024, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) unanimously selected Robert P. Mauch to succeed Steven H. Collis as the Company’s President and Chief Executive Officer (“CEO”), effective October 1, 2024 (the “Effective Date”), at which time he will also join the Board. Mr. Collis, who has served as CEO since July 2011, will retire from the role of CEO and become Executive Chairman of the Board as of the Effective Date, to serve for a period of one year. Mr. Mauch, age 57, currently serves as the Company’s Executive Vice President and Chief Operating Officer.

    Read the 8-K filing
15. Jan 16, 2024

    On January 12, 2024, Henry W. McGee, a member of the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”), informed the Board of his intent to retire and not stand for re-election as a director when his term expires at the Company's 2024 Annual Meeting of Stockholders to be held on March 12, 2024 (the “2024 Annual Meeting”). Mr. McGee's decision was not the result of any disagreement with the Company and he intends to continue to serve as a director for the remainder of his current term. Effective as of the date of the 2024 Annual Meeting, the size of the Board will be reduced from 12 members to 11. Mr. McGee has served as a director of the Company since 2004 and currently serves as Chair of the Governance, Sustainability & Corporate Responsibility Committee and as a member of the Board’s Audit Committee and Executive Committee.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.